Biomed Valley Discoveries
Biotechnology ResearchMissouri, United States11-50 Employees
Biomed Valley Discoveries, Inc. (BVD) is a clinical-stage biotechnology company on a quest to make a meaningful difference for patients and their families. HOPE FOR LIFE BVD is guided exclusively by our founders’ intent of bringing hope for life to patients. Our founders, Jim and Virginia Stowers, envisioned a biotech company that could approach the pursuit of groundbreaking medicines differently from the traditional biotech model. Jim Stowers founded the asset management firm, American Century Investments (ACI), which today manages over $200 billion in assets. Over 40% of annual profits from ACI are directed to the Stowers Group of Companies, including the Stowers Institute for Medical Research and BVD, providing a stable and sustainable source of funding to further scientific and clinical innovation. BIOTECH, PURPOSEFULLY REIMAGINED Our secure funding and our commitment to our founders’ intent have enabled us to build a purposefully reimagined biotech company, with distinct approaches to candidate sourcing, research and development, compassionate use/expanded access, collaborations, partnering/out-licensing, and overall corporate infrastructure. CURRENT PROGRAMS Our 3 novel oncology assets hold the potential to address significant unmet needs: -Ulixertinib, a highly selective, first-in-class ERK 1/2 inhibitor -TEM8 therapeutic antibodies, including TEM8-directed antibody drug conjugates (ADCs) -Clostridium novyi-NT, a cancer-fighting bacteria PARTNERING & OUT-LICENSING We are structured to take assets through early development to proof-of-concept. While we have the flexibility to advance niche/orphan disease programs through registration, our model is primarily centered around partnering and out-licensing our programs beyond this point. A prospective partner or out-licensee could be any organization with a vested interest in advancing a de-risked asset for a serious unmet medical need, from large or mid-size biopharma companies to venture capital firms.
1-888-653-2347 
support@leadiq.com 
